These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 21712324)

  • 1. Big Pharma would like to befriend you.
    Lenzer J
    BMJ; 2011 Jun; 342():d4075. PubMed ID: 21712324
    [No Abstract]   [Full Text] [Related]  

  • 2. Big pharma moves from 'blockbusters' to 'niche busters'.
    Dolgin E
    Nat Med; 2010 Aug; 16(8):837. PubMed ID: 20689537
    [No Abstract]   [Full Text] [Related]  

  • 3. Steve Carney talks to Vincent Lee on the pharma industry, the FDA and public education with respect to drugs and their development.
    Lee VH
    Drug Discov Today; 2005 Nov; 10(21):1411-4. PubMed ID: 16243258
    [No Abstract]   [Full Text] [Related]  

  • 4. Big Pharma's Commedia.
    Steele FR
    Cell; 2005 Dec; 123(6):971-3. PubMed ID: 16360023
    [No Abstract]   [Full Text] [Related]  

  • 5. Biotech's new colossus. Move over, Big Pharma. Amgen boasts better growth.
    Stipp D
    Fortune; 2002 Apr; 145(8):144-6, 148, 150. PubMed ID: 11961884
    [No Abstract]   [Full Text] [Related]  

  • 6. [Europe 1992: big brother is watching you].
    Offerhaus L
    Ned Tijdschr Geneeskd; 1989 Oct; 133(43):2111-2. PubMed ID: 2812101
    [No Abstract]   [Full Text] [Related]  

  • 7. Internet eases negotiations for FDA, drug firms.
    Goedert J
    Health Data Manag; 2001 Mar; 9(3):14-5. PubMed ID: 11277031
    [No Abstract]   [Full Text] [Related]  

  • 8. Promoting, improving and accelerating the drug development and approval processes.
    Graul AI
    Drug News Perspect; 2009; 22(1):30-8. PubMed ID: 19209297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The drive to reform the FDA gains momentum.
    Gatty B
    Hosp Formul; 1995 Mar; 30(3):178, 177. PubMed ID: 10141250
    [No Abstract]   [Full Text] [Related]  

  • 10. Trials and error.
    Jacobs T
    Nat Biotechnol; 2005 Dec; 23(12):1481. PubMed ID: 16333284
    [No Abstract]   [Full Text] [Related]  

  • 11. BIO and biogenerics.
    Feldbaum CB
    Nat Biotechnol; 2005 Jan; 23(1):17; discussion 17. PubMed ID: 15637607
    [No Abstract]   [Full Text] [Related]  

  • 12. Modernizing medical product development through collaboration.
    FDA Consum; 2006; 40(3):5. PubMed ID: 16909486
    [No Abstract]   [Full Text] [Related]  

  • 13. This Dutchman is flying.
    Watson N
    Fortune; 2003 Jun; 147(13):89-90. PubMed ID: 12827720
    [No Abstract]   [Full Text] [Related]  

  • 14. Outsourcing challenges FDA to strengthen oversight abroad.
    Torres C
    Nat Med; 2010 Feb; 16(2):139. PubMed ID: 20134448
    [No Abstract]   [Full Text] [Related]  

  • 15. Biogenerics standoff.
    Herrera S
    Nat Biotechnol; 2004 Nov; 22(11):1343-6. PubMed ID: 15529145
    [No Abstract]   [Full Text] [Related]  

  • 16. A critical tipping point.
    Zuckerman MB
    US News World Rep; 2002 Apr; 132(13):72. PubMed ID: 11993366
    [No Abstract]   [Full Text] [Related]  

  • 17. Millennium mergers bring pipeline.
    Dove A
    Nat Biotechnol; 1999 Dec; 17(12):1151. PubMed ID: 10585700
    [No Abstract]   [Full Text] [Related]  

  • 18. Tax reform fears driving big pharma mergers.
    Kutscher B
    Mod Healthc; 2014 Jul; 44(29):24-6. PubMed ID: 25189018
    [No Abstract]   [Full Text] [Related]  

  • 19. A look at pharmaceutical ads.
    Salyer D
    Surviv News (Atlanta Ga); 2001 Jul; ():6-7. PubMed ID: 11683018
    [No Abstract]   [Full Text] [Related]  

  • 20. The world according to Codex.
    Levy AR
    Altern Ther Health Med; 2005; 11(6):14-7. PubMed ID: 16320855
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.